Merck

Merck is a leading global pharmaceutical company. Recent news highlights its involvement in two significant areas: artificial intelligence in drug development and prescription drug pricing in the United States. A Merck executive predicts that China could approve the first fully AI-designed drug as early as 2026, signaling a potential revolution in drug discovery and development processes. This reflects Merck's active participation in leveraging AI for pharmaceutical innovation. Simultaneously, Merck is one of the major pharmaceutical companies that recently agreed to lower US drug prices as part of a deal announced by President Trump. This underscores Merck's role in addressing the ongoing debate and political pressure surrounding the cost of prescription medications in the United States, making them relevant in discussions about healthcare accessibility and affordability.